$BIO news
The latest BIO stock news: headlines, filings, AI summaries and sentiment for $BIO, updated around the clock.
- Bio-Rad Reports Q3 2026 Results with Improved Margins Amid Life Science Challenges
- Bio-Rad Laboratories Reaffirms 2026 Revenue Growth Guidance and Operating Margin Targets
- Bio-Rad Laboratories Reports Q3 Revenue of $656.4 Million and GAAP EPS of $2.65
- BIO-RAD LABORATORIES, INC. - 10-Q Filing
- BIO-RAD LABORATORIES, INC. - 8-K Filing
- Longleaf Partners Fund Exits Bio-Rad (BIO)
- Chip Stocks Rebound and Goldman Sachs Secures Major M&A Deals
- Stocks Making Significant Premarket Moves: Regeneron, Dominion Energy, Macy's and Others
- Ariel Investments Re-adds Bio-Rad Laboratories to Ariel Focus Fund
- Bio-Rad (BIO) Q2 2025 Earnings Call
- Bio-Rad Reports Q2 2025 Earnings Results
- Bio-Rad Laboratories Reports Q1 2026 Earnings Amid Regional Challenges
- Bio-Rad Laboratories Reports Q1 Earnings Amid Middle East Conflict Impact
- Bio-Rad Reports Q1 2026 Earnings with Mixed Results
- Citigroup Lowers Bio-Rad Laboratories' Price Target to $300 Due to Process Chromatography Concerns
- Cue Biopharma Appoints Lucinda Warren as Interim President and CEO